These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11428934)

  • 1. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis.
    Carotenuto A; D'Ursi AM; Nardi E; Papini AM; Rovero P
    J Med Chem; 2001 Jul; 44(14):2378-81. PubMed ID: 11428934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55.
    Albouz-Abo S; Wilson JC; Bernard CC; von Itzstein M
    Eur J Biochem; 1997 May; 246(1):59-70. PubMed ID: 9210466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.
    Breithaupt C; Schäfer B; Pellkofer H; Huber R; Linington C; Jacob U
    J Immunol; 2008 Jul; 181(2):1255-63. PubMed ID: 18606679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
    Brehm U; Piddlesden SJ; Gardinier MV; Linington C
    J Neuroimmunol; 1999 Jun; 97(1-2):9-15. PubMed ID: 10408984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.
    Clements CS; Reid HH; Beddoe T; Tynan FE; Perugini MA; Johns TG; Bernard CC; Rossjohn J
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11059-64. PubMed ID: 12960396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
    Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
    J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
    Ichikawa M; Johns TG; Adelmann M; Bernard CC
    Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily.
    Gardinier MV; Matthieu JM
    Schweiz Arch Neurol Psychiatr (1985); 1993; 144(3):201-7. PubMed ID: 7687365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
    Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
    J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
    Lolli F; Rovero P; Chelli M; Papini AM
    Neurology; 2005 Sep; 65(5):781-2; author reply 781-2. PubMed ID: 16157927
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
    Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
    Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
    Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
    J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
    Reder AT; Oger JJ
    Neurology; 2004 Jun; 62(11):1922-3. PubMed ID: 15184588
    [No Abstract]   [Full Text] [Related]  

  • 18. Imperative role of glycosylation in human MOG-HLA interaction: molecular insights of MOG-Ab associated demyelination.
    Jayananth P; Madhumitha R; Ramya L
    J Biomol Struct Dyn; 2022 Sep; 40(15):7027-7037. PubMed ID: 33663341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
    Mathey E; Breithaupt C; Schubart AS; Linington C
    Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
    Khare M; Rodriguez M; David CS
    Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.